Trial
NCT01386710
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
—
Condition
Glioblastoma Multiforme
Intervention
Bevacizumab and Carboplatin
Why stopped
PI left previous institution study will reopen at new institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-01